<SEC-DOCUMENT>0000885725-24-000040.txt : 20240424
<SEC-HEADER>0000885725-24-000040.hdr.sgml : 20240424
<ACCEPTANCE-DATETIME>20240424063409
ACCESSION NUMBER:		0000885725-24-000040
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240424
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240424
DATE AS OF CHANGE:		20240424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		24866664

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bsx-20240424.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0f8dc062-01c6-433e-9b88-b5ca1f629703,g:97498d41-49cb-4013-9222-87658e085e10,d:89a3ef85e8ab4726a222a14c4c52b374-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:bsx="http://www.bostonscientific.com/20240424" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20240424</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-24">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-25">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20240424.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-24</xbrli:startDate><xbrli:endDate>2024-04-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-24</xbrli:startDate><xbrli:endDate>2024-04-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-24</xbrli:startDate><xbrli:endDate>2024-04-24</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i89a3ef85e8ab4726a222a14c4c52b374_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">_____________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric>  </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">_____________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">April 24, 2024</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.114%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">1-11083</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">300 Boston Scientific Way</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Marlborough</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">01752-1234</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;             &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">508</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:1.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.915%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-17">Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-18">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-20">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-21">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-22">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-23">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i89a3ef85e8ab4726a222a14c4c52b374_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.02.&#160;&#160;&#160;&#160;RESULTS OF OPERATIONS AND FINANCIAL CONDITION.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;24, 2024, Boston Scientific Corporation issued a press release announcing financial results for the first quarter ended March&#160;31, 2024.  A copy of the release is furnished with this report as Exhibit 99.1. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.01. &#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND EXHIBITS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;Exhibits</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit No.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Description</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="q12024earningsrelease.htm">Press Release issued by Boston Scientific Corporation dated April 24, 2024</a></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;document</span></div><div><span><br/></span></div><div id="i89a3ef85e8ab4726a222a14c4c52b374_10"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2024</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BOSTON SCIENTIFIC CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Susan Thompson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Susan Thompson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Corporate Counsel and Assistant Secretary</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>q12024earningsrelease.htm
<DESCRIPTION>EX-99.1 Q1 2024 EARNINGS RELEASE
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i02a72130b1814de990ece242e88e8691_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:36pt"><img alt="imagea.jpg" src="imagea.jpg" style="height:98px;margin-bottom:5pt;vertical-align:text-bottom;width:678px"></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Boston Scientific Announces Results for First Quarter 2024</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Marlborough, Mass. (April&#160;24, 2024) -- Boston Scientific Corporation (NYSE&#58; BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> basis and 13.1 percent on an organic</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $495 million or $0.33 per share (EPS), compared to $300 million or $0.21 per share a year ago, and achieved adjusted</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> EPS of $0.56 for the period, compared to $0.47 a year ago.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;Our exceptional results this quarter were fueled by our talented global team and the strength of our diversified businesses and pipeline, including the initial U.S. launch of the FARAPULSE&#8482; Pulsed Field Ablation System,&#8221; said Mike Mahoney, chairman and chief executive officer, Boston Scientific. &#8220;We continue to invest for the long term in our innovative portfolio and clinical science to benefit patients globally while delivering differentiated financial performance.&#34;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">First quarter financial results and recent developments&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.34pt">Reported net sales of $3.856 billion, representing an increase of 13.8 percent on a reported basis, compared to the company's guidance range of 7.5 to 9.5 percent&#59; 15.0 percent on an operational basis&#59; and 13.1 percent on an organic basis, compared to the company's guidance range of 7 to 9 percent, all compared to the prior year period. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.34pt">Reported GAAP net income attributable to Boston Scientific common stockholders of $0.33 per share, compared to the company's guidance range of $0.29 to $0.31 per share, and achieved adjusted EPS of $0.56 per share, compared to the guidance range of $0.50 to $0.52 per share.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.34pt">Achieved the following net sales growth in each reportable segment, compared to the prior year period&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.25pt">MedSurg&#58; 10.3 percent reported, 10.9 percent operational and 7.8 percent organic </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.25pt">Cardiovascular&#58; 15.9 percent reported, 17.4 percent operational and 16.3 percent organic</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.34pt">Achieved the following net sales growth in each region, compared to the prior year period&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.25pt">United States (U.S.)&#58; 12.7 percent reported and operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.25pt">Europe, Middle East and Africa (EMEA)&#58; 12.7 percent reported and 13.3 percent operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.25pt">Asia-Pacific (APAC)&#58; 18.3 percent reported and 25.9 percent operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.25pt">Latin America and Canada (LACA)&#58; 17.9 percent reported and 12.7 percent operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.25pt">Emerging Markets</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; 22.6 percent reported and 28.2 percent operational</font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">Commenced launch of the </font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FARAPULSE</font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:7.15pt;font-weight:700;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline">TM </font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Pulsed Field Ablation (PFA)</font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">System</font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> in the U.S. and completed enrollment in the second phase of the ADVANTAGE AF clinical trial studying the </font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FARAPULSE&#8482; PFA System</font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> for the treatment of patients with persistent atrial fibrillation (AF), which additionally evaluates the safety and effectiveness of adjunctive use of the </font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FARAPOINT&#8482; PFA Catheter</font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> for cavotricuspid isthmus (CTI) ablations.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.34pt">Commenced enrollment in the NAVIGATE-PF study of the use of integrated cardiac mapping with the </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FARAPULSE PFA System</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> using the </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FARAVIEW&#8482; Software Module</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> in conjunction with the </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FARAWAVE&#8482; Nav PFA Catheter</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> for the treatment of paroxysmal and persistent </font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">atrial fibrillation</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.34pt">Initiated the DISRUPT-AF registry &#8211; a collaborative, observational, prospective, multi-center, non-randomized, real-world registry designed to obtain clinical experience with the </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FARAPULSE PFA System</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> for the treatment of </font><font style="color:#212121;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">atrial fibrillation</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> in the U.S.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.34pt">Announced the U.S. Food and Drug Administration (FDA) approval of the </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">AGENT&#8482; Drug-Coated Balloon</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, the first drug-coated coronary balloon in the U.S., which is indicated to treat in-stent restenosis in patients with coronary artery disease.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.34pt">Announced the FDA clearance and initiated the U.S. launch of the </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">WATCHMAN TruSteer&#8482; Access System</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, a steerable sheath designed to improve implant success of the </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">WATCHMAN FLX&#8482; Pro</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">WATCHMAN FLX&#8482; Left Atrial Appendage Closure Devices</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.34pt">Announced U.S. FDA approval for an expanded indication of the </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">WaveWriter&#8482; Spinal Cord Stimulator (SCS) Systems</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> for the treatment of chronic low back and leg pain in people who have not had prior back surgery.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.34pt">Expanded an existing relationship with </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Scivita Medical</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, a China-based medical device company, for strategic co-development of future endoscopic devices and global distribution of certain </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Scivita Medical</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> gastrointestinal and pulmonary single-use imaging devices.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.34pt">Completed a public offering of &#8364;2.0 billion aggregate principal amount of EUR-denominated Senior Notes. The company intends to use the net proceeds from the offering to fund a portion of the previously announced agreement to acquire </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Axonics, Inc.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> (Nasdaq&#58; AXNX).</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.34pt">Released the 2023 Performance Report, detailing the ways in which the company is advancing innovative care, empowering people and contributing to a healthier planet, while performing with integrity.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:105%">1. Operational net sales growth excludes the impact of foreign currency fluctuations.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">2. Organic net sales growth excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">3. Adjusted EPS excludes the impacts of certain charges (credits) which may include amortization expense, goodwill and other intangible asset impairment charges, acquisition&#47;divestiture-related net charges (credits), investment portfolio net losses (gains) and impairments, restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), European Union Medical Device Regulation (EU MDR) implementation costs, debt extinguishment net charges, deferred tax expenses (benefits) and certain discrete tax items.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">4.Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Net sales for the first quarter by business and region&#58;</font></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase&#47;(Decrease)</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br>March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operational<br>&#160;Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact of Recent Acquisitions&#47;Divestitures</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Organic Basis</font></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Endoscopy</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">577&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.4&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.1&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.3)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Urology</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">513&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">469&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Neuromodulation</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">256&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">234&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MedSurg</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,412</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,280</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10.3</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.6</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10.9</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3.1)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7.8</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cardiology</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,872&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,606&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Peripheral Interventions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">573&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">503&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiovascular</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,445</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,110</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15.9</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.6</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17.4</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.1)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16.3</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,856</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,389</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.8</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15.0</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.9)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.1</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase&#47;(Decrease)</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operational<br>&#160;Basis</font></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,258&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,003&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">803&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">712&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">647&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">548&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LACA</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,856</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,389</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.8</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15.0</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">4</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">648</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">529</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22.6</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.5</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">28.2</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Amounts may not add due to rounding. Growth rates are based on actual, non-rounded amounts and may not recalculate precisely.</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Net sales growth rates that exclude the impact of foreign currency fluctuations and&#47;or the impact of acquisitions&#47;divestitures are not prepared in accordance with U.S. GAAP.</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Guidance for Full Year and Second Quarter 2024</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The company estimates net sales growth for the full year 2024, versus the prior year period, to be in range of approximately 11 to 13 percent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on a reported basis, and 10 to 12 percent on an organic basis. Full year organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales. The company estimates EPS on a GAAP basis in a range of $1.43 to $1.48 and estimates adjusted EPS, excluding certain charges (credits), of $2.29 to $2.34.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The company estimates net sales growth for the second quarter of 2024, versus the prior year period, to be in a range of approximately 10.5 to 12.5 percent on a reported basis, and approximately 10 to 12 percent on an organic basis. Second quarter organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales. The company estimates EPS on a GAAP basis in a range of $0.35 to $0.37 and adjusted EPS, excluding certain charges (credits), of $0.57 to $0.59.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Conference Call Information</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston Scientific management will be discussing these results with analysts on a conference call today at 8&#58;00 a.m. ET. The company will webcast the call to interested parties through its website&#58; </font><font style="color:#0000ff;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">investors.bostonscientific.com</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Please see the website for details on how to access the webcast. The webcast will be available for approximately one year on the Boston Scientific website.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Boston Scientific</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world.&#160; As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at </font><font style="color:#0000ff;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.bostonscientific.com</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and connect on </font><font style="color:#0000ff;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">X</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, formerly Twitter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Statements </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.&#160;Forward-looking statements may be identified by words like &#34;anticipate,&#34; &#34;expect,&#34; &#34;project,&#34; &#34;believe,&#34; &#34;plan,&#34; &#34;estimate,&#34; &#34;may,&#34; &#34;intend&#34; and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.&#160;These forward-looking statements include, among other things, statements regarding our expected net sales&#59; reported, operational and organic revenue growth rates&#59; reported and adjusted EPS for the second quarter and full year 2024&#59; our financial performance&#59; acquisitions&#59; clinical trials&#59; our business plans and product performance&#59; and new and anticipated product approvals and launches.&#160;If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.&#160;These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.&#160;As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Risks and uncertainties that may cause such differences include, among other things&#58; economic conditions, including the impact of foreign currency fluctuations&#59; future U.S. and global political, competitive, reimbursement and regulatory conditions&#59; geopolitical events&#59; manufacturing, distribution and supply chain disruptions and cost increases&#59; disruptions caused by cybersecurity events&#59; disruptions caused by public health emergencies or extreme weather or other climate change-related events&#59; labor shortages and increases in labor costs&#59; variations in outcomes of ongoing and future clinical trials and market studies&#59; new product introductions&#59; expected procedural volumes&#59; the closing and integration of acquisitions&#59; demographic trends&#59; intellectual property&#59; litigation&#59; financial market conditions&#59; the execution and effect of our business strategy, including our cost-savings and growth initiatives&#59; and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements, except as required by law. This cautionary statement is applicable to all forward-looking statements contained in this press release.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Amounts reported in millions within this press release are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Non-GAAP Financial Information</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A reconciliation of the company's non-GAAP financial measures to the corresponding GAAP measures, and an explanation of the company's use of these non-GAAP financial measures,&#160;is included in the exhibits attached to this press release.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONTACT&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Media&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Emily Anderson</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investors&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jonathan Monson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">617-515-2000 (office)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">508-683-5450 (office)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Media Relations</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investor Relations</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0000ff;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Emily.Anderson2&#64;bsci.com</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0000ff;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">BSXInvestorRelations&#64;bsci.com</font></td></tr></table></div><div id="i02a72130b1814de990ece242e88e8691_7"></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions, except per share data</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,797&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss)&#160;before income taxes</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">493</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">314</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to noncontrolling interests</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to Boston Scientific common stockholders</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">495</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">300</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share - basic</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.34</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.21</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share - diluted</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.33</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.21</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Weighted-average shares outstanding</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NON-GAAP NET INCOME AND NET INCOME PER SHARE RECONCILIATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Expenses</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Preferred Stock Dividends</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to Noncontrolling Interests</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to Boston Scientific Common Stockholders</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact per Share</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,648</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,973</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">675</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(67)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">608</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">493</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">495</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.33</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Non-GAAP adjustments&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(214)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">214&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">214&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">184&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">182&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition&#47;divestiture-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains) and impairments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.01)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EU MDR implementation costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,692</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,680</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,012</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(80)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">932</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">833</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">832</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.56</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Expenses</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Preferred Stock Dividends</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to Noncontrolling Interests</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to Boston Scientific Common Stockholders</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact per Share</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,349</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,797</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">552</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(108)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">444</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">314</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">300</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.21</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Non-GAAP adjustments&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(203)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition&#47;divestiture-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(27)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains) and impairments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EU MDR implementation costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discrete tax items</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,388</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,523</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">865</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(78)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">787</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">687</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">673</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.47</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="33" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">For the three months ended March&#160;31, 2023, the effect of assuming the conversion of 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP net income and adjusted net income were reduced by cumulative</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"> Preferred stock dividends</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:100%">, as presented within our unaudited consolidated statements of operations, for purposes of calculating net income attributable to common stockholders.  On June 1, 2023, all outstanding shares of MCPS automatically converted into shares of common stock. </font></div></td></tr><tr style="height:21pt"><td colspan="33" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">An explanation of the company's use of these non-GAAP financial measures is provided at the end of this document.</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Q2 and FY 2024 GUIDANCE RECONCILIATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:120%">   </font></div><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Net Sales</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2024 Estimate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Full Year 2024 Estimate</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported growth</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.5</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.5</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.0</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Operational growth</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.5</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.5</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.5</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.5</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of acquisitions&#47;divestitures</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Organic growth</font></div></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.0</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.0</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.0</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.0</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Earnings per Share</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2024 Estimate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Full Year 2024 Estimate</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP results</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.35</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.37</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.43</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.48</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.48&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.48&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition&#47;divestiture-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted results</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.57</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.59</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.29</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.34</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i02a72130b1814de990ece242e88e8691_13"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:4.5pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders and adjusted net income (loss) per share (EPS) that exclude certain charges (credits)&#59; operational net sales, which exclude the impact of foreign currency fluctuations&#59; and organic net sales, which exclude the impact of foreign currency fluctuations as well as the impact of acquisitions and divestitures with less than a full period of comparable net sales. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To calculate adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders and adjusted net income (loss) per share, we exclude certain charges (credits) from GAAP net income and GAAP net income attributable to Boston Scientific common stockholders, which include amortization expense, goodwill and other intangible asset impairment charges, acquisition&#47;divestiture-related net charges (credits), investment portfolio net losses (gains) and impairments, restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), EU MDR implementation costs, debt extinguishment net charges, deferred tax expenses (benefits) and certain discrete tax items. Amounts are presented after-tax using the company's effective tax rate, unless the amount is a significant unusual or infrequently occurring item in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 740-270-30, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">General Methodology and Use of Estimated Annual Effective Tax Rate.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Please refer to Part II, Item 7. Management</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s Discussion and Analysis of Financial Condition and Results of Operations in our most recent Annual Report filed on Form 10-K filed with the Securities and Exchange Commission or Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations in any Quarterly Report on Form 10-Q that we have filed or will file thereafter for an explanation of each of these adjustments and the reasons for excluding each item.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The GAAP financial measures most directly comparable to adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders and adjusted net income (loss) per share are GAAP net income (loss), GAAP net income (loss) attributable to Boston Scientific common stockholders and GAAP net income (loss) per common share </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> diluted, respectively.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior periods. To calculate organic net sales growth rates, we also remove the impact of acquisitions and divestitures with less than a full period of comparable net sales. The GAAP financial measure most directly comparable to operational net sales and organic net sales is net sales reported on a GAAP basis. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the accompanying schedules.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales and profit or loss. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe that presenting adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders, adjusted net income (loss) per share, operational net sales growth rates and organic net sales growth rates, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision-making and allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bsx-20240424.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0f8dc062-01c6-433e-9b88-b5ca1f629703,g:97498d41-49cb-4013-9222-87658e085e10-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20240424" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20240424">
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20240424_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20240424_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20240424_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverDocument" roleURI="http://www.bostonscientific.com/role/CoverDocument">
        <link:definition>0000001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>bsx-20240424_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0f8dc062-01c6-433e-9b88-b5ca1f629703,g:97498d41-49cb-4013-9222-87658e085e10-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20240424.xsd#CoverDocument"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_074eecd9-acd8-4595-94af-2ddc21ca5a96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntitiesTable_074eecd9-acd8-4595-94af-2ddc21ca5a96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b6876d4d-22a5-4851-8f2c-cbfe299657bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_074eecd9-acd8-4595-94af-2ddc21ca5a96" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b6876d4d-22a5-4851-8f2c-cbfe299657bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b6876d4d-22a5-4851-8f2c-cbfe299657bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b6876d4d-22a5-4851-8f2c-cbfe299657bc" xlink:to="loc_us-gaap_ClassOfStockDomain_b6876d4d-22a5-4851-8f2c-cbfe299657bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f070e3e9-4850-4703-a238-fbb1018802a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b6876d4d-22a5-4851-8f2c-cbfe299657bc" xlink:to="loc_us-gaap_ClassOfStockDomain_f070e3e9-4850-4703-a238-fbb1018802a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_478cfb7e-33c2-47af-be15-7d899ddc470f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f070e3e9-4850-4703-a238-fbb1018802a3" xlink:to="loc_us-gaap_CommonStockMember_478cfb7e-33c2-47af-be15-7d899ddc470f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_171571cc-9c36-4b11-b8a8-c664c5d81ee5" xlink:href="bsx-20240424.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f070e3e9-4850-4703-a238-fbb1018802a3" xlink:to="loc_bsx_SeniorNotedue2027Member_171571cc-9c36-4b11-b8a8-c664c5d81ee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_42f794e8-c106-4cd9-ac8c-cd60c5f8ae76" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_DocumentType_42f794e8-c106-4cd9-ac8c-cd60c5f8ae76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e8efa08a-db63-47cf-9ad3-0893ac082484" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_DocumentPeriodEndDate_e8efa08a-db63-47cf-9ad3-0893ac082484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8c5b71b5-36c0-439f-9bf9-149858e28d70" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityRegistrantName_8c5b71b5-36c0-439f-9bf9-149858e28d70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e3baf114-6bc5-4112-ad0b-d8bea18fdecf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_AmendmentFlag_e3baf114-6bc5-4112-ad0b-d8bea18fdecf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_51ed4e34-3126-4e4f-88f4-63f769c97c6d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityIncorporationStateCountryCode_51ed4e34-3126-4e4f-88f4-63f769c97c6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_206060be-e8ab-429a-929a-a3f5021d187b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityFileNumber_206060be-e8ab-429a-929a-a3f5021d187b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_70786ded-ad9d-444c-9b6a-467c8c39eafb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityTaxIdentificationNumber_70786ded-ad9d-444c-9b6a-467c8c39eafb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_256661ea-829d-4579-9a37-05e5d62ef623" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityAddressAddressLine1_256661ea-829d-4579-9a37-05e5d62ef623" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2aa89a6a-02fd-4b07-955a-deb578b2eb09" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityAddressCityOrTown_2aa89a6a-02fd-4b07-955a-deb578b2eb09" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_99eae795-3d64-4ab3-91a0-bd83246aaffd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityAddressStateOrProvince_99eae795-3d64-4ab3-91a0-bd83246aaffd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8c6e4b35-6784-4ee8-bf86-7331b00c160d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityAddressPostalZipCode_8c6e4b35-6784-4ee8-bf86-7331b00c160d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9f995111-8ea7-4500-a797-298bb453e80c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_CityAreaCode_9f995111-8ea7-4500-a797-298bb453e80c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4684360b-895d-4ca5-b8c0-88251a620f67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_LocalPhoneNumber_4684360b-895d-4ca5-b8c0-88251a620f67" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_11c5c094-eac6-4528-bc4e-029653768049" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_WrittenCommunications_11c5c094-eac6-4528-bc4e-029653768049" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_2a3390bd-29d2-42b4-89a8-e3fc96875379" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_SolicitingMaterial_2a3390bd-29d2-42b4-89a8-e3fc96875379" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_8fb09cd6-3ff0-4360-9327-3448d2902e4b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_PreCommencementTenderOffer_8fb09cd6-3ff0-4360-9327-3448d2902e4b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_76b8aecf-de63-4003-8dd0-afa60c468afd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_76b8aecf-de63-4003-8dd0-afa60c468afd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_37995507-6ab4-42b8-ac49-18ccf3613fb7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_Security12bTitle_37995507-6ab4-42b8-ac49-18ccf3613fb7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_89de9a38-4d1f-4dbf-a4f8-06ca139c30c9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_TradingSymbol_89de9a38-4d1f-4dbf-a4f8-06ca139c30c9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c6b8a741-3497-418b-b8d2-969eecf41768" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_SecurityExchangeName_c6b8a741-3497-418b-b8d2-969eecf41768" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5d4f7060-da44-4924-b7c3-740a71fe4b2f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityEmergingGrowthCompany_5d4f7060-da44-4924-b7c3-740a71fe4b2f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f1c35aa3-4335-4113-a4e4-5bafe0eabf96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityCentralIndexKey_f1c35aa3-4335-4113-a4e4-5bafe0eabf96" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>bsx-20240424_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0f8dc062-01c6-433e-9b88-b5ca1f629703,g:97498d41-49cb-4013-9222-87658e085e10-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityInformationLineItems_0c9add68-480c-4930-aabe-e3ff4a080dfb_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_910d1a09-110b-4844-bf0b-8b3aa9b7cb67_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_183cbc17-3c36-45cb-bb26-37b3e71df8a2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_8c8d9454-16fb-4265-a03f-13ccf6c38804_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_e1fc1d78-7f31-4aeb-9dce-ec1a9e11411f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_37cb52fa-3d6c-4574-8059-7d7fe1fd2eb6_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_535f3285-b2db-4c1a-a1a1-d96b68d2d6ca_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a580ae27-be97-4a3e-b099-774a789e111b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_05873a12-b280-4966-b604-292ce100dd2c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_44dcd7d7-41df-4840-bc48-9160f54da4eb_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20240424.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_daa369d6-762c-41a2-af8a-afbb344e9694_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_198e2989-e5e7-4064-93de-4ef2ac25ff76_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_c4ab8731-b6ea-482d-81dd-301180bb98be_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_91d57f21-0295-4f27-96a8-6f966673b8d4_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_df7c19fe-eb09-4271-a3b1-c185c53ff407_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_59f9ea7a-9e81-4d91-adcd-91bd4c65416c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0eae8b1a-7852-4fd3-bf65-fe63c1701f31_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8ee0277b-0d48-4cba-a15b-8a63319bb908_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_a07ec166-0123-47bd-a86a-4c87ae7d28a0_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_bafb5216-8029-4101-93af-bb2a943633f1_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_57e3f02c-41b6-4ca8-82db-05c4c3527d78_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3e0110fb-297c-45e0-8382-d9f8caf46df7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a9d375b1-44c2-4797-abcc-2cc4da8301d0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_5ca942ae-fa16-4db0-881f-9723e394c91b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c0ff8d3c-96ba-4590-a5ba-c3711274c54e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_9206ee6a-cbe0-4a5a-bce8-beb246e2cd9e_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_57ce60b8-0717-4fc7-bdff-236faf358922_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b7d97d40-e9e2-45e7-a801-b6d9d52532d8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f360e0ae-a5ab-4f84-a894-a7ee8a1a6dce_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>bsx-20240424_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0f8dc062-01c6-433e-9b88-b5ca1f629703,g:97498d41-49cb-4013-9222-87658e085e10-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20240424.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d2cb9229-7f72-44fc-a993-1781e763c094" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_074eecd9-acd8-4595-94af-2ddc21ca5a96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2cb9229-7f72-44fc-a993-1781e763c094" xlink:to="loc_dei_EntitiesTable_074eecd9-acd8-4595-94af-2ddc21ca5a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b6876d4d-22a5-4851-8f2c-cbfe299657bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_074eecd9-acd8-4595-94af-2ddc21ca5a96" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b6876d4d-22a5-4851-8f2c-cbfe299657bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f070e3e9-4850-4703-a238-fbb1018802a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b6876d4d-22a5-4851-8f2c-cbfe299657bc" xlink:to="loc_us-gaap_ClassOfStockDomain_f070e3e9-4850-4703-a238-fbb1018802a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_478cfb7e-33c2-47af-be15-7d899ddc470f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f070e3e9-4850-4703-a238-fbb1018802a3" xlink:to="loc_us-gaap_CommonStockMember_478cfb7e-33c2-47af-be15-7d899ddc470f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_171571cc-9c36-4b11-b8a8-c664c5d81ee5" xlink:href="bsx-20240424.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f070e3e9-4850-4703-a238-fbb1018802a3" xlink:to="loc_bsx_SeniorNotedue2027Member_171571cc-9c36-4b11-b8a8-c664c5d81ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_074eecd9-acd8-4595-94af-2ddc21ca5a96" xlink:to="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_42f794e8-c106-4cd9-ac8c-cd60c5f8ae76" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_DocumentType_42f794e8-c106-4cd9-ac8c-cd60c5f8ae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e8efa08a-db63-47cf-9ad3-0893ac082484" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_DocumentPeriodEndDate_e8efa08a-db63-47cf-9ad3-0893ac082484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8c5b71b5-36c0-439f-9bf9-149858e28d70" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityRegistrantName_8c5b71b5-36c0-439f-9bf9-149858e28d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e3baf114-6bc5-4112-ad0b-d8bea18fdecf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_AmendmentFlag_e3baf114-6bc5-4112-ad0b-d8bea18fdecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_51ed4e34-3126-4e4f-88f4-63f769c97c6d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityIncorporationStateCountryCode_51ed4e34-3126-4e4f-88f4-63f769c97c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_206060be-e8ab-429a-929a-a3f5021d187b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityFileNumber_206060be-e8ab-429a-929a-a3f5021d187b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_70786ded-ad9d-444c-9b6a-467c8c39eafb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityTaxIdentificationNumber_70786ded-ad9d-444c-9b6a-467c8c39eafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_256661ea-829d-4579-9a37-05e5d62ef623" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityAddressAddressLine1_256661ea-829d-4579-9a37-05e5d62ef623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2aa89a6a-02fd-4b07-955a-deb578b2eb09" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityAddressCityOrTown_2aa89a6a-02fd-4b07-955a-deb578b2eb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_99eae795-3d64-4ab3-91a0-bd83246aaffd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityAddressStateOrProvince_99eae795-3d64-4ab3-91a0-bd83246aaffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8c6e4b35-6784-4ee8-bf86-7331b00c160d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityAddressPostalZipCode_8c6e4b35-6784-4ee8-bf86-7331b00c160d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9f995111-8ea7-4500-a797-298bb453e80c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_CityAreaCode_9f995111-8ea7-4500-a797-298bb453e80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4684360b-895d-4ca5-b8c0-88251a620f67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_LocalPhoneNumber_4684360b-895d-4ca5-b8c0-88251a620f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_11c5c094-eac6-4528-bc4e-029653768049" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_WrittenCommunications_11c5c094-eac6-4528-bc4e-029653768049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_2a3390bd-29d2-42b4-89a8-e3fc96875379" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_SolicitingMaterial_2a3390bd-29d2-42b4-89a8-e3fc96875379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_8fb09cd6-3ff0-4360-9327-3448d2902e4b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_PreCommencementTenderOffer_8fb09cd6-3ff0-4360-9327-3448d2902e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_76b8aecf-de63-4003-8dd0-afa60c468afd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_76b8aecf-de63-4003-8dd0-afa60c468afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_37995507-6ab4-42b8-ac49-18ccf3613fb7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_Security12bTitle_37995507-6ab4-42b8-ac49-18ccf3613fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_89de9a38-4d1f-4dbf-a4f8-06ca139c30c9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_TradingSymbol_89de9a38-4d1f-4dbf-a4f8-06ca139c30c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c6b8a741-3497-418b-b8d2-969eecf41768" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_SecurityExchangeName_c6b8a741-3497-418b-b8d2-969eecf41768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5d4f7060-da44-4924-b7c3-740a71fe4b2f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityEmergingGrowthCompany_5d4f7060-da44-4924-b7c3-740a71fe4b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f1c35aa3-4335-4113-a4e4-5bafe0eabf96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d84f9a07-ff81-4e76-836f-7cb50e002819" xlink:to="loc_dei_EntityCentralIndexKey_f1c35aa3-4335-4113-a4e4-5bafe0eabf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>imagea.jpg
<TEXT>
begin 644 imagea.jpg
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MJ;-4=HT<<!<&G$P>:C[<A9L.PY&39ZTCQ,_% \#\KX 9;SD+!.XVZWU@^AO
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MP2N_-,'(T/B[_8\N $(S ;/><Q %?-B,MX&0C,#FCL!5<>9]P<D0C#V04*'
MF.S#?===<1WK3D&% D51%$51%"70)$8HV''@&%[]M;EK1 'WD_TY='_/H9/6
M%K<.=?I,->E_*'=-A*E0H"2 FRH4-!J0"*& 1F7OXS)XY,OJZ#ARGEF3WQM'
M%R9.**!Q% *G(JRN!ISW,8"!0D&NQ H%--GO]3LL;H$*!8JB*(JB*$J@28Q0
MT*#?=)>/0I^# =<SE$7+H2'6K_[!40F'3Y[%S@/'L>O@"1P[=0[7$SF*^.R%
M2]AY\+@1,$Z=O6!]Z^+RE:MF=+,GNP^=,*LT/)"]JO&;'OVZ%I:L37@P0ZX
ML?_H:3GW<?D\9=*26)C6,^?C[G_H^!FLVW'0!%M<OFDO]DC:[]#9V2F*6U,H
MH&41XX/[:044:?ZO&5;C1%*$ MJL#X 9;P)+"P''PZV#>I!DH8 F^SXJGVWD
MV;\3%BY1H4!1%$51%$4)-$Y" 84 )^C<MQP6@OMS5$-0!O%1Q,&^.W-%5.@T
M7AQD_Y9&.W3\++J-6X@?:O;#Z[\WQ]/YZN/9[QO@G3];XK>&@S%X1J2CL^S$
MQMV'4;;=&'Q4K!U>+M@,+^9OC _^;HWR'<=A[LIM&!FV$JV'AN**.. D;,56
MM!H2@N .8_#N7ZV-P&&F>6>J@ =RUD#C 3,Q;<D&3%BP%N/GK\78N:MQ4)QT
M)Y9NV(5:O:8@2YDN>/'GQG@J;SV\(.?_K%0G5.LV"0O7[+"VC,TR<?2Y6AV/
M/]&<9PV&AZQ CPF+\&>3H1@A_[99L64?*LJUO/]7&SS^;1T\F*L&'LM3!V__
MT1*E6X_$)KE^Y>9QZPH%MEE+*&8)[H+EF^-V^R=5*#!&L> -*V[!5.O ;B2+
M4&";'(.!$0_=YFJ!"@6*HBB*HBA*H(DE%%BQ!FJ+ WSUZC5<N!B%XZ?/8<_A
MDYBT<!U^KC=0_!+Q+;C]YY7PWA^M,$S:K/XR48[QT=]M$/1!:3SW?0/\TW($
MFHOCWFQP"/YH/!3IOJGC6CVA?'<L6+W=VLN9*8O7X\4?&^+9O/6-6-!UW$)T
M&CT?9=J.QG_E^U1R/7=_6AZY*G;'Y2NNT=6_-1R"^[)5->>YAR,)>"V6SY0J
M2V7CA#_W0P,\DZ\^GA;'_Y&O:F-6Q":SK\WQT^=1O]]T/):SALF'3"4[HGKW
MR6@NUU"KUU1D"^YJ\O"A+ZH9(>'PB1BA@:, RK8?*PY_33R;KP'2R?G,J SZ
M:_3Y/BR-WI.7F&W[3%J"=%_5,K\Q70_)/D'I@UUYS\[@#TKAG<*ML'[G(;.]
M<N.Y]84"&A]Z*4RO%&R*46&QXQ8DBU!@&5=.8-R"+9V JVX#&))5**#)<;Z2
MXZURB8.W)2H4*(JB*(JB*($FEE! $[^#/?,YRG=#QA(=\+\"3?!HGMKBL)9'
MT+LE\?IOS5"M^R1,6K0.)SV&^7OCZK5K:&-6%JB&H'>*X]MJO;%Y3]S>\.6;
M]QK'.^BM?\21KH]ALYQ%B/#UN_&4./L?%VGKZ"AOD.]R5NR!H%?^1JY*/7 Q
MRC5_>?>ADUBW\R"V[CV&JMTFN483T$^2SP=SUT3_J>'8MN^H.29M[8Z#L:82
M<+K"=]7[&+^*H[9;#PV+,Y+BPJ7+Z"/.?EISK260NU)/.>8QZU=@[Y%36+O]
M@*3AJ!%9'OU:\I;^7J8*2/59!3/:HLF@6;@G:Q7\4*NO$5<V[SV"%9OWF7MU
M[Q=5S;F-P/!N"2/>^)IFK@2.VT,HL"U#,![(7@7-ALQ&U&57@3JV*/F$ AKC
M%LQ\&UA=%;AXT)PB^84"FASKE5/ Y-LT;H$*!8JB*(JB*$J@B3VB0$R<53-\
MOOLD8QS&_VN#P7CGSU:X.TME//E=7104Y[3%T!#,6+K1KVD"W<8N=/6:BX/-
MJ08<4N^-D&5;<#][^S\LC8=RU<#4Q1NL7UQP&D'^.@.,7S-VWAKKV[@P]L$+
M/S8RPL,YAVD1[4?.C1$*Q-]Z]*M:6+3:>;H N1!U&3_QO!^6,FG[I]5(ZQ=G
M:O::@J"/)5_?+X4\U7H[QBZ@\_]TOGIR?E<Z4F>MC-<*-C.?#?O/-%,]/"G:
M8KBY=G.O*'!('H4MWVK]JMQ(;B^A@&8I5L6E<!\Z=PH7EB>O4$!CW (NH;CT
M=^!TI.M:<I]W.?>.3G]B38[WR$F@PT7@=M,+5"A0%$51%$51 DTLH8 ^A_@*
M% $\.7+RK)F__V/M_L91#GJK&.[.6@592G?&P&D1B++B 'BR9ML!_/>'AJYS
MB-/,'GE?L/<_>[FN9@H"IT^G+][!!/.SV7OX)%[[K3G2YJJ)\ V[K&^=X50
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M>DS,<!IA&<793Z)8$$<H"%MFQ()[YB['DUL.X[X3UP,:M^ +QBVX!9<65:%
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M*[-VM7'D;8'!-CG_@[+O<#_BI:S9N LO,B:%G7<TZ]HYE>;=7YN:&!)UND]
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MEOO6H,=$7$I@KP;STJQ$X&74D4W4Y<OXL\$@JZS(^7A>GC]3>5./,="H/S"
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MG<>ZKHO.G].^4GX>^K(:&O:>@D-'I( ' *]" =/$O/5J;MMZFI05SF/_N_X
MK-L2$V3)'[J.G"/7+6GARX_'DOSYL6J/.(V.Q#(G<A,>RRUU-IU+2_SZN^%
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M%,Q9NLZL3A&=AS<BW7*?'\U9#9MWQETV\LRY"RC2<) 1P\R[RRZ?5D.'WS'
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M4*'@E#BW7Y3I%#O=<HWO_-$"AX_%G:^9W&S8<0#W,8]Y_WANR>ND"@5GSUU
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M5\4>:#)P%EH,F8U<E7J@^_B%YK>;Q:TO%# >P4=E\,%?K3%MZ0;KR#$DEU#
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0>6FE=     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140580468302928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Document<br></strong></div></th>
<th class="th"><div>Apr. 24, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 24,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M,G[QMDQN^-EGFA*AZ1\+;$=.\U%!2T8%EP*V0%,%6R$?$@\/;VV\95"]MR[
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MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ 0S286 =!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !#-)A8@)3,T>X    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !#-)A8F5R<(Q &  "<)P  $P
M        @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $,T
MF%A&\C,YWP0  "D5   8              " @0T(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !#-)A8GZ ;\+$"  #B#   #0
M        @ $B#0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $,TF%B7BKL<
MP    !,"   +              "  ?X/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( $,TF%@WU&O^-@$  "L"   /              "  ><0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " !#-)A8)!Z;HJT   #X 0  &@
M    @ %*$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" !#-)A899!YDAD!  #/ P  $P              @ $O$P  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  !Y%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bsx-20240424.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="bsx-20240424.htm">bsx-20240424.htm</File>
    <File>bsx-20240424.xsd</File>
    <File>bsx-20240424_def.xml</File>
    <File>bsx-20240424_lab.xml</File>
    <File>bsx-20240424_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bsx-20240424.htm": {
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20240424",
   "dts": {
    "inline": {
     "local": [
      "bsx-20240424.htm"
     ]
    },
    "schema": {
     "local": [
      "bsx-20240424.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "bsx-20240424_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20240424_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20240424_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 25
   },
   "report": {
    "R1": {
     "role": "http://www.bostonscientific.com/role/CoverDocument",
     "longName": "0000001 - Document - Cover Document",
     "shortName": "Cover Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bsx-20240424.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bsx-20240424.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock [Member]",
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "bsx_SeniorNotedue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bostonscientific.com/20240424",
     "localname": "SeniorNotedue2027Member",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "documentation": "Senior Note due 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000885725-24-000040-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-24-000040-xbrl.zip
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M!OI%W,YY;FWS<T[,1_$ZYB;_"N<&E+/68P$/12<$XR-BP)+RJY^=W#*>Y!8
M.P>P'F,[3AK_EG7S7\2=NSK)>C#F@3%B:(+5"G:V7)RHLUONJ5'-,LU_9'31
M^KF<4 !31R#<Q=_C=N:M;2ZRT!429%"?#X.:"QQF(A-72]^[H1^*VH^F_IP-
M@ /&@(ZY/ZN]ZX,D2-)AMZ0;CFGP[E3"2@Y+ON"#N*#D_V,UJP"CUX^W,45E
M: =7_Y1"RT::OG3:_=9'TNLW^JT>.?KA]EK-+]UVOPUC;70^DM;OS5\:G9];
MI'EU>=GN]=I7G0.28&]%PF]4CL!G //PE'QL@JU?+%0/.&CSWJ +:P9]IH?A
M,3<4VEJL16#=""R5J?]W'Y^=Z7\EVO7IJGM)MC?N4I\QMG1CVPZ JF+\>M^P
M(ZNJ>B2,N2]/ZQD#6MQM=?JDV[J^ZO9?W_1O1^7UEV[O2P/([%\10*X^P!.Q
M\N2J2ZSBB?>>7'TB_5]:1T_& NC. ;?1[./PK6J^<$3C?P.O/4X[FF0D') N
MFX1"D9/TF5'@'I.*L!N,;PG]FGGO:X] NFMMZ;5B^R]#XG@$V&]35?/@%P,<
M"S7":H9'9\8,NC98,'=[,_7&1'"?V(53'3-;=7^/$R-+6_#_(;'=-2;194,N
M,>"C.O F91_X-1^N>GW I%ZS#6#<_M1N@B'5!41N]+4E]0UN'I>>9^HGK2EU
ME:8>Y53,J294$CEA+OI;'N$!X4H2=P3^"1/O7T)]%75\EA9P0@$S:0!7?#J1
MK)9^.4O#47&4SM"5SL94#,$M<4*EPG$-79(;)A1WJ9]THON+7R?>2K6:K13S
MZ+ H\(R4EW:<^#)9X%5N]?>\E;6L]:_,K+73[U:V6"SM6.,%!E78L:4'!U5X
ML*F<YGS,?9A?%)6+3#Z3%IY0#_<-:O9D2BR8TA6969GD</+RJX"Y7Q1J!]#*
M)&E(QRZ:810H,6N&WC+V8_P:XP>*341X@^W<@7X!%B;FTULJUD0[$Y54WK<8
M;R+;DPE\FY]X?CYQGT%A!Q KX74Q4[<,T+]*_HW5>V5UGT[;20#0U8TM\[V4
MJ6-\K%0MV@7S0=:_1IQ96;QU<.U$(P()!0G5B GR1R2X]+B+W,'5G"^BARXF
MAC3@_]//[__B\KB!91AYYQ*#P@25E\12])TRHYWM9GM9TAI/_' & K2L8*03
M9M^OJDY.&UE';-/^]*-5,L]6_Z:DO+QCN$\<;'B>8%(F_WR&-JP4 \N9>MXT
MR0>]D4YZ\YUT\AN=W8?$TQT\SZ6.F_#U2O3#V[EY4<G4+\&_!1L]C(:CO76D
MP>U*7(,YP_7N]Y;63A6'(R5U1Y%D2LE-B\$AX@.;1'-??\G2YR\E\-<@U=3_
M#Y_$IF\2Z35AV;?*1<R%R6^,91QBI@^Y+_0TF#Q)&(X6Q+4 U>,3ZI/6E+F1
MXC>,7 T 4IA\_R39?$3EW:N<@+00%)<7"5@<0LJVUR6$[89@=$E[K$R]:%96
M-DJV;_5S"';,]2@,[GE!EIVIERIY R1OQ1@_?LTXN0O^O9-$,9]-D$02:!I/
MT:[V(S3R"'C4%/BS3L(>E*/#T-4<,?>KSJ>D$U@W)X*C^^"$4^(P/[PE?*!?
M?H)UEE2,7\F ^T@DET"Q8H#@'E$AD7P<^8H&+(RD/R,2 %X.9KIF4B%T8 YI
MZH7@BX6XHEX)" UFZ;M!Z$/G6 _7<HZFN:QME)'EV!X:V,DO8$;72NOL[4/$
M$HLE:]=8HI6M5O)[B;55B]F*57Y*K,VA[M<A6'.!9R2R.="?LP><&Y\-5G@3
MLV5[+6Z 1/KD2\!1I<AE[VGNS?8P]IO@"@0<?<,H2+P?N6IP.F'H.Q2D58'.
MS*$NCTMIM5PHG#TAXO-,#-VKNYAP"<A88!.91$)&J-@ #=T(U*Q@%Q,E1^WN
M@=D ]3@,H^$J<F*52?-3E]AY,PL%U[B72J1T)9WGP=O>DT\^+_8F_TORWPMU
M5AM0=@DK @YB6^$O?"_"?\<B,DYXM"KZ5H&"Z;,@_:VI.Z+!D"W+?@%@6)=\
M$_^C$/]KP1#Z,0%;IQ*AJ2/ S4%[=CLU*'XO:@"L,MP%7BTO!G*=2GB&?>*\
MWTXIXK)O:G&,:M&6,F+B$<I1>E..3<J19T;AQ-U..9*RNT3D%UPC2^O+(;S.
M!0LP=@.9 $=RD1=00IN2E@:*Q"T$^E^U%P@BD35CC=LII:24K5J[96EL_KV8
MWT_VAHV)( ]G;[S\H#2GBB^:4O(\Z%+98B<]4^_CN;PXE] =$1>/KQQPT_*@
MG!!4!]]ZL[$3^M\I$SI)QIZ6!I8N&@"BMR,.O]PA[2ZY#PDH)NL%D>#S>"0E
MY15M;#]HX]A+GF^\.,TLV]$*-C=:RIEZ?$B/Z"-BI^3O .<6F5!!;J@?,3+!
M,VRC9TVI^OZF(U'M6+/G<U')U#_T?G_C\_[%/K4VXQSG^^8\PLKRWKI5!>2!
MP?X[%%]CQ9@;K-])SM6#/,YO RTV[EEG2W;Q'R0^;DKPO*DD'H *'CG]SO(&
MG\KFM9!A6QHRWICY2)G=%1=L^PFXL(W[6CZ8^]H./'3@&7%FQ-4;J#"LKV!F
M,9US>6]WDTL"0P3O'T<^)$,1WJH1Q@$FN.-)0<O9 +K0)RKBW1*SF'J\][9*
MX%>KFL^3$TQG*)_I'9.T,-=G,29X%@/S.N-@@NT8]IJVEB(*<:.%>:,86+BK
MM]!L=O,V_6976U_%<Z!Y:JWG^9/3 /<6?=LQ82-.?DJI^ED3U8QIVC+P9G][
M9_(0$[658.'!\$,I_. !%<;DC[5XP%<2'4:@[<QG+EYD%80ZT!5)IDO!E"?I
M%'BC$(_W4?6Q/IQ9W9<_P\[U!5B(' '0!F\$N^$2Z@&&T,!%P:2NBR="L##>
M$N11X<DXD<+;%&7+G]!YE&T1'+)'IBMSV3U&6;UWY\4DC*>Q)IA/,4UNY1:,
M.V=#QQ#-NRK4 8\C4INK[)*D=N]BC2VO]BC/K_88B3L#9\@,1S#ZU: #Z+1&
M_5LZDV@1[?W^C[0U!#,#J!745349C4&U9@=*K6OW6Y?$SIKV&K6(_W9;O2^?
M^ST\TWUUW8H/@,9W;'QJ=QJ=9KOQF32O.A_;^"+[Y(.U?T12\<'SLV.])EP%
M1!\<CDE/3P^?KDDV;RZ<.>&X9^01"HB$&:6@'(P"!M(@ -!R$;3ND Q*1+Z2
M&@'C9#(A%?DSTD=.28R7EU2XHW@(>2L>0I:0!B#F9':7:Q9W L;,(!(!EZ.[
MFP2Y3,Y>HRG6FHZXPQ6I5K/6 ^;.QBEX+5/7!Z;P8'YOG38Z:&J$MA4;:S&?
M6X#-2 C<O$K.L.-!F30A$-:7):YA ,SW]>KF,#!M8='TR$\_5FP;Z.$^\_1W
MZTS/*:Q% 'E,YQ7/UZ+*U@8K%DJ:7BR0]/!^?@KJ%A9((B/G#^@"ESVLYW/J
M<#]N7?='%9'Q$$YA]"*A@R^2<7=X"AY@K9_?T89<PR4Y27;<F.J4VN_AZL;>
M*=H)L%+[29HU-C=D 1.@!LN'MO"ZN0B &#N5D3M*>EU%D\=*ZP'!M9HU0>\V
MH>L=ANJ+EBY;G7YZ@=$O[0_M?F]'1#U0*K&WE">?*(]\S-"/:@)3%.B$&Y?'
M37\_,ND*/D'Q/BY*5V;0LH%2Q+E]'<_YABD[&#P;'0\>R*%KS2\63_'9P0=(
MXLLS_[1PN6<4EO1@*)-5/CM28YUX 4#:G2_\VN@ S'[8./$TM-^_#H4>F?ZM
MQQ7++.Q+*)OA#2Q@U[C(M-&Y@+G'8SX?J:+Q$5E#KU^N+H9. =&7-2LZE'C^
M@>!5B)Z7V%BP3&'AMDZ>B L>"<?VQ2XON89G1WM^RRL6S75W+#[RD-)K<%$/
MZVX>RS&N7OOG3J/_I;MZK]GQV@7KM>QZ(> 4.V-_1ESH;#BYI:E_BKX9'6N'
M[U17Z"X'U;S(GQ&71A@(6W3IH$LPWR7,)KP(XQN+' :6_0#7 FQ(KRE) 7 5
M6!1 '=T<C=0H%$"HM\FL?*UXM6_;Y8TMS\'&H[\@ZY'IC,5L]1M'T;9.]\MG
MJY7]-&5G*X7]M%3$IJK/E(.H=]..*L$9;QR\2\K]:R1MW[?_-Q!7>I7$?>.R
MPF^>LK"*SW#,XD4/;3Q/[Z]B[F=_-57-R1SI1= "Z8_"\40N!)!V2#)[47%]
M;&KAT?'^E?']-;'V7]QE!$-8^C^X."7-$6>#>:2*$;SR43)?[[XTI.2XSZ_0
MBQ),43';(:'J-40$<O%_.:3_FZ+Z_P%02P,$%     @ 0S286&+Y9/TP P
MVPH  !    !B<W@M,C R-# T,C0N>'-DW59;3]LP%'[OK_#R/#>7%MI$I$@#
M,2%U;.*B\88<YZ2U2.S,=FCY][/=&BB42[4]3.M+$Y_O.Q>?KZ?GX'#9U.@.
MI&*"YT'<CP($G(J2\5D>7%V>X'%P..GU#CYA?/WE?(J.!>T:X!H=22 :2K1@
M>H[T'-!/(6_9'4$_:J(K(1N,)XYV)-I[R69SC9(H&7J8M\HLJL8EC?83',5T
M'P\' \!I,1[C8H^2N-I/TE$T^#S+TM$P'9?#& ]36N!A% ]PFB0)'H_V]\80
MC?<@CIS3I<H4G4-#D"F-JVRI\F"N=9N%X6*QZ"\&?2%G81)%<7C];7KAH,$:
M6S-^NX%>%K+V^$%HS051X.&%6FZ@"Z&TX(HR<T&L8K1/11/:JJ-A,O0DZY*]
M$81QI0FG#T%*+;&^;T'%VTG&'EJ[#1292\1)'""BM61%I^'$=.(8*M+5.@\Z
M_JLCM<D,2M/F&FPC-P!/S)K(&>@STH!J"84=ZIST$+)=8$TKI$;\A8N*J,*E
MWBD\(Z2UU$& 5EV;"DJT$Z-%*P-WE6[EA%!KY4^P/>DO51F$[V;P1 AQFJ;A
MTG9V>P9;>^3PV#[B.,&#>(>PKS7[X['-&_:\OY'#HZIWR\'S_C"'K?I]30OO
M,=V[^F :SI$"VI^)N[ $]A$=/H?;ARW*(YP+[?CV9'W6MHQ78G5@CNS]9?X2
MSZ'R\^'%$-JB5/>5$4FEJ-^1==A*T8+4#-33 >8<S"54>6#&&/:_WIM60M\D
MXA$O_&\*P9I- %!F$KARIX_U>!>V)7F@3!MJ6-W0/UQ^"=6NY1L*X^Q_*+XF
MQ:[%&PK4.]9MB9?&CEB9!T?";!]^JPB0M5V=G[[_=^.B;Y)]%!_GL3&3R'UB
MA!\7&(P<^^'@('Q.>N:N4U!^YQ/W_%SR:_(:\@:1DIIV]>Z\39%MI:T/_>VN
M!T^X.7E6[QO3R<ZF]3+@.F(D<7,!G EY)LR&UX'1Q^@;- 5(LU@42DM"S:Z@
M96>T9*=J'KP*YZPV"K$R6L'=\I,923)17CJ)E)UTF9BYVQG?3'?V[:L479L'
M*SC3T)B%9 5_V(:R4C2$\5-CM)ZLR%QQJ_$]Z?T&4$L#!!0    ( $,TF%A*
MP]3D8 @  " \   4    8G-X+3(P,C0P-#(T7V1E9BYX;6S=FVMOVS@6AK_W
M5WBS7Y<Q;^(E:#OHIIU%,+T$308SV"\&+X>.4%D*)+E)_OT>*79SL9M,(W46
M#@JXCDSSO#P/=?B*DE_^<KDH)E^A;O*J?+7']NG>!,I0Q;R<O]K[_?178O9^
M>?WBQ<M_$/+GOS^_G[RMPG(!93LYK,&U$"<7>7LV:<]@\D=5?\F_NLEQX=I4
MU0M"7O=?.ZS.K^I\?M9...5RW6S]:7U DXF!*DXH"XI((8!8;PSQ67 L*6XU
M%?^:'U@MK8F2$6F#)Y(R02SGG!BM,@/49,!HWVF1EU\.NA?O&IC@\,JF__/5
MWEG;GA],IQ<7%_N7OB[VJWH^Y92*Z;KUWJKYY4;["]&W9M;::?_IMZ9-OJTA
M=LNF?WYX?Q+.8.%(7C:M*\--  P?VV]?O*TFFUY_B$V;_*#IO_^^"J[M 3TZ
MA,EW6W1_D74STATBC!/!]B^;N/?ZQ61RG3E7A[HJX#.DR>KM[Y^/-I7F93N-
M^6*Z:C-U18&*^Q[:JW-XM=?DB_,"UL?.:DC?5;\><B<JZ^3\L^MM.EC3&0JI
MP](#P:-0=E-\1(W;>A^N^5M?)$)RRZ(=4?%FWZ/JK18N'S/!&UV/H+;OB"Q@
MX:$>4^J=?F_I7(N\K[#KTE=-6Y5-R+&<YBD/^Z%:3'N9AQ56Y'6E?5RF;RY)
M5UNIY+*7<_?[M^0@][S,NU+R'O]<==*%'"X,+ELH(UR7DG6\H@IW&A5=(:N^
M9;YP'HK^Z"Q"/GN'X=JKH[);/=Q*)!RUL&AFT<AD'=4D)8-+ &A%C%")Z. S
M"I1RP^PFNV8]%QH(^_/JZQ2C($ NNC==RL0UO0=C7^=OP(AR:$Z=+V!&M00(
MT1(7HB$RLQFQTB7"8PR<!9<YJX8/8AWNKNX;\F_J]0A69\4/%?=45XO1B;75
M&"F[!H*:]R95':%&.X,?]6?J02BJ!N*KO;9>PLW!JFQQVKXKH)O.>&[!_.:$
M^7'@RX;,G3N?G;1HC+J.#@O7-)_225N%+V\N\V;F%;J5*"/AW&5$FHP1DW@@
MP2?@UJI,^_# !$BN\3V?5:3K60!%VZR/W$R'1\6,.#T>6&>W3)>GL:U^1HZW
MS9B!\&_K>=NO"G])T>S>:C\2_4TU(V+_KE6Y@3XRKNJGY/KOF06):@H";">*
M$HD7-<1Q84CRGE%F#.5.["C].\;O_PC_1U+\,Z!7BT55]H(^]$9P)K4)R6L@
M0@2.@K"X>6 9T=%8BU4.)::QF=\7,2;R;>YYD_=0,O=!#TKK)F?Z5,YHLV<G
M4.95_;%J(2X!DZ]7DIAFF68A$!N$(M(S1KQQA@2E9,BB80#9(Z;]@>YWEN%8
M*1OQ;.U\R/H*YA3;SB1/VDK P(RBCFM#8K (145#EHQ#ZSK(E=^.]O>1_$GV
M_,FI&_%$O*WC&.J\BN_*^!87F1D87-JI<21Z)7".AD2LBX)08X4+U'!IY"@L
M[X1]-E"?GLR13]#K,7Z&>=ZTM2O;CVX!,Q,RKYG/B% !"Y"PJ,<G2YBT)C/
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MZ;VLH-POKU^L#G<OW:]$7[_X'U!+ P04    " !#-)A8Z..?0IX,   S:P
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MQ+1+8Y"0GHV-+J)=&FT"VAOC+YX_K9U*S^OG]/?S?+DI9C%A2"69P0A S!)
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M&^GZ[(^^H\Z!;-O6.I>/#6S>-W8_EI_*XEMNZ4RHUA!GF0!0$0J(%/4BLD0
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M)Y1AI[,E#R*-DV,L>+2-'IAQNN+EFGZ.$(6@7.0?@(#,=(#<@#3597GDG'6
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M,%9V91=U(HTW3$J7#P]J</V\;;(V8XP1 T[CBDDI<=IJPJWQ7F8"#'WJD,>
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M0KSJ,A5L&+<]QK5#3LMWU%4!T4G[KGV1LJFUQ+U1;'+JRST<PZ;ML>DWH'%
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M]C+$&MEV].8,P\L';9=JMK.-5%2OB?Q>N]ZX\6UB!\I:IU4Y>M9N=EV_@"B
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M755-%H/#"? +B#_KZ'(4&OCEAS)VW2K<^J_!W^'@[\2V3DT2J2,& /A?ME%
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M$0_2J1RL# *%E5U)-U8##-$VX\2#B#!05\TM_V9A7_=%NL"/ACCQ@/!J\_%
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M0/7XH+HZ&Y6!B8')E.TM7 QL',5C=12W=;2X")[B >\,NQ6!WGU-O7_'832
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M95T!"C!Y^$A_')=$W++H>&7A3J9'V1XBX7XGG_D3]UC@'3<"2#N*)._$$<5
M(A+D5L#K()("W >E.F$ ;%V^F:.DTJ\BC$1 'EP.K?(N=\F%& SP"6*K+WP@
MQ#9)MM8%]?A36O\"E?>CA =#ZFH/] $]T&U,1]6L>CU#9\Z'0M^\>*8N*>%/
M[!R)7W:L6FVX2%(:,JP!DWQ-E"70-UL,L17N[IY]]PSSYYK=UD6>!79*U=KI
M44X#&Z 6"JAVJ7G:-$ U0,T[4.MUL_QK8)I[F)[8E59N-UL?!58*!9=:K58T
MK6;P>L1XK=H&K\80%P&I:RZTV+L=-CC)S]#,-GT#U8) M5HQY^*-IU@0L%8L
MIW#'2C8%V />ZW8K@O*7=ON.4)432%WA^-/'>FN!UH79O;FQHKE@YQNDPM!T
MPS0]Q,34[8& KOQ'WXB4)*8VR:B//CWBB5.IFKN17B23LX.KP@^$5$8 #;*V
M0RJ[63>D,D)HR+5O<AE!?$7ZZ1W<)6723Q]DR8,,0]T_8JYWE/_TL=8\]_@3
M"R,.U;.RVF'./!*PB+A]*GMX<Y(KF7>H%R?9V[\Z[4 H=5(]-5'JBU2J5PR>
MS,W9FX64H51&2C4:AE(FVC+DVC>YC!R^XFJD[<?QAQC$W$/((F,7JL,CWS3P
MB)Q^<H2!C+F.+/-Z6],$,B]2J58S>#+.@0'6'BEE;I@T(FC(M7]R&3E\13BS
M_:T49JGM($L>8I1Z'>#2&F[P)IB/J"M\+E1(ZHLPQ(BT1WD0?E+Q*Q\,*9=J
M,_@AQJ?&YAAR&7+EA%R.6?4VE-KT!*29]#?*RI!K[^0R<OB*:'7[VOT0PYK+
M;^3F\SU&+#[#@$6?:'/%NIS+!<:)V2.8>6FM;E;6C((VEM\ *^>4,FN01@0-
MN?9.+B.'18I5\K=F9$H>Z\K:Y_1FI(C^2'.IA.2DPP+6/=0MGL:X&'(9<AER
M&7(=/+EJ9LK1 ,N0:^_D,G)8I*V?Q8QD>.A*%C$5R?"(#0YR#<WH'4,N0RY#
M+D.N@R>78S+3&6 9<NV=7$8.7Q&[[#U#Y%P3N0A8EM]*TE:W5IB[U8M\#9)3
MJK9:1;M:QMS7=7Q M4MUIVJ :H":=Z"V&G4#4P/3O,/TI)G?J]4-3O(SM&:K
M:=29@6G>8=HP,#4PS3],S47J!B?F(G4#U0.":J-IIF4,3',/TXI5.TX/,5EN
M2AM+N^6H6Z/7+T%EN%MZJN]5Z* GXH[/9CMO:C&U[+F6%3)06Y0!:$.*YW4+
MV:_1X!Y_2JN8^@1737EWM&$U6+/J]0RZZ'PH])5O9^IF!/[$SI&,9<>J 3D6
M1D)#AC5@Y/)I?^KS2D@2]1G\7S)&!E"^'Q(6>,PC-U2Z?:U>JW:).!6G6E)E
M6;?+W(B(+J%A& ^ ?>JQ*P(88XAY:N!5W:I7_@QU!!Z-!/3U0KV-.,+I3J9'
M"Q\BX7XOD0?H.PM)FYS<7-P]?"(\B 0)^U3"0ZC+%0/H&1 &"I-G&A(:1+SL
M<3]&*I=4;D_H =0J)'3OA^O'.("N% /=,^J[L:]3Z$!UEW</%FF[+D =^NZ/
M2N1+NWVGDH;R -IBJD*:K,%//W^&-@CT.W;A>6=$W'@0:U9OE8.JOC,> 7+<
M##R=HJ\F&0@+]X"IX?YP!DP*R1#X"55"OYXYU C,B"6) QI['!\"@)2%5K>*
MA!'\4*E:D65BR*3B7U@BP&0RC"5(6X*.E+N PVD>1I'DG3BBB#B TS2(^L('
M+1=:A'P-R-_C@)$QP*GO0[<B:#Y =$RA$*%): SZARI!]D<)Y+&[:Q!KD;%W
M HQ8JS<=>ZG>3 JM.7@\5T]K,RZ(*9K/HLOW.67:Z)18R'EK-.">Y[-MA0^O
MU%_M (^;^S08:VQM7@8PSM%?0A*'+'D(OX PE)7Z[O* !BZG/ADP&L8HB!Q5
MCD#=!^H\TK8+-+OZ%MYY O0W#,2:B1X4<?^JU$8JL>H?7:2#+Z>E^85W2YP4
M%U6@_&"^,E\5Y:M$/&N./NFUZ.@^<R_J)^([_:'VU\\JDT]H!VQ\'*W^Y!4]
MG/ZW+R?:K\?*'<GH]S+MPO=GU'^FHW"V%?!:RW.CFN_0"\UFZ/*F%.GI2_,P
M#O;YUZ\/CU]OR</%]>7MX_75]06Y^'I_]_6^_7C]]?;5@-A6WQ=4ONK[/QSE
M<U_]#WIA-?+EV_7G]NW%);F_O/AZ>W']V[4:Q$/.1W'R+?5E/ZTP$KM%!"%D
MR_VP[0P=T?Z'QR#@4A;]+(;X4NK@]Q8<]@?JLW E:P=4]D!8$TTRY\Z,F:W=
M_-E)#!B<3X<A.TM_.4\]:!ZH/JJ/SF<;J"^&ZJH]_3I1$J>G5JM>13V1>&%)
MPXD*L90*F9N+U.]JIU:]WEKYNF+9*]^MJ]:&EW4G3]6N?U>OYJJS+U9;RU1M
MQO,'*]W^1A8/7D-^)_/_+VJ92J*[E=*^A,@"0F,V/Q=_/)2XBGV?_ ^C<@U!
MWHN1I5.ULXL;2]8W<DVVD]_$\^IL8H<XX/^"/[*,>!-H*!9EW@N%8HUV$0<O
MJ(>WBL#.5L.S#?R>X5U=S",]*9ZC?H9L')D'ON?3D-G&;X,'M(VY^!?#E'<L
MF6]@U7SWA/[S\4'+,=#:,[1>8;\/%H40-!D4&@6W#6A5#;3V *TWY(4#4^3L
M*S%<-FY>#X94[V3!G2/0&>+&4K+ '9&N'[M1K/<<%"M;7+:A@X+>9CZ.W0\H
MBR8T7-KW@#;L-16.H1#X'0M##9?R,Z#WV/+7[,G=L9]BUV%L7].]@=2?GT^:
M[+<["L_8-J&_";JV%709:)E9I7VCT"BX?:/P8*%E%)R95=KXK!)U_XBYWO@:
M_O2QUCP'AY2%$8]P>_HA!DXGH*&W=#_UOH,FPZ'\#>;89Y..A)F&0_D8S$'/
M(LD>#;C[QAFD9//XW)%Y[.^!N<F5O"^^;H 3.9/%=X=H1P-.QX S'YS8SBS6
MT>#8*-F<<,(H6:-D<\N))=[XBK0%.^-1<NKT51D2<G8@]9+* & 0DB&3Y $3
MNA3J9"I PZKH(^QO.)K:J*Y^_9[SD]5LYR=W5.U+1U.+18-LAXG-T51S--4<
M37TUV<S15(,&@X;C.Z"J,HI)%L9^M+!.NY']#SD;[ZO34R\,,L^14L6J'N/F
M#@/8 @-V*RG5"P+85[@;!MM%P[9MU;9RK45!L&T 6T# ;N4>YR( -GMZ_YRG
M3-YE(N9<73B?#67M@8"N_$<G7&8_ABP(5T^6%7@[5L6RG6V>[#.TVJJW=QAD
MK;4,!'-$JQ>4^+);%PZOY.%8LLF1B_D3%V65KCRYT<7M4]EC(3EQ)?-X%*Z>
MURVT_%2J1M?DE%;'8NYL \$\T>I@-/T]Z'6)29HDWM.$UP?(Z2=&VQM1RQ&M
MCD;;VP:".:*5"6X,$0P1#!$,$0YUPN,KWGR;W%:K[DL]4->V9OR*G-+J:%Q;
M \$\T:J &GSY!H-V>M-XI@VGRX^WK3[;=FB[2=XW_GQ(S:I=?_6<[_I[%^TW
MMFG*2, !2\"ID8"-;HDUPG*HPN)8CA$68RZ.6@*J-2,!RP.CMZ>">.0#%I);
M]DSNQ8 &F\X%D?8@*5=SK"9F-A@*O6GG3"W;\B<V26B A]BG/DQH6IE\0CM
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M4E4\ &@!-21S(^C,U$A7#,HB5['$99(2$6JU1'T2<.C5@$(%U'=CW"N$E;]
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M4$L! A0#%     @ 0S286%UV\TJ[#P  0FP  !               ( !
M &)S>"TR,#(T,#0R-"YH=&U02P$"% ,4    " !#-)A88OED_3 #  #;"@
M$               @ 'I#P  8G-X+3(P,C0P-#(T+GAS9%!+ 0(4 Q0    (
M $,TF%A*P]3D8 @  " \   4              "  4<3  !B<W@M,C R-# T
M,C1?9&5F+GAM;%!+ 0(4 Q0    ( $,TF%CHXY]"G@P  #-K   4
M      "  =D;  !B<W@M,C R-# T,C1?;&%B+GAM;%!+ 0(4 Q0    ( $,T
MF%A?>2\K%0@  +L^   4              "  :DH  !B<W@M,C R-# T,C1?
M<')E+GAM;%!+ 0(4 Q0    ( $,TF%B?#?_G>#X  -P,!  9
M  "  ? P  !Q,3(P,C1E87)N:6YG<W)E;&5A<V4N:'1M4$L%!@     &  8
*B0$  )]O      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>bsx-20240424_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20240424"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bsx-20240424.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2024-04-24</startDate>
            <endDate>2024-04-24</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-24</startDate>
            <endDate>2024-04-24</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-24</startDate>
            <endDate>2024-04-24</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-24">0000885725</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-04-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">1-11083</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">683-4000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-2" id="f-17">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-18">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-20">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-21">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-3" id="f-22">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
